Orexin-A is a neuropeptide consisting 33 amino acids with two intrachain disulfide bonds, namely Cys6-Cys12 and Cys7-Cys14, and is a potent stimulator of food consumption and gastric acid secretion. In contrast, orexin-B, a peptide containing 28 amino acids without disulfide bond, which has no stimulatory action of gastric acid. The objective of the present study was to characterize the receptor-mediated mechanism of orexin-A-induced stimulation of gastric acid secretion using orexin-A- 
Abstract
Orexin-A is a neuropeptide consisting 33 amino acids with two intrachain disulfide bonds, namely Cys6-Cys12 and Cys7-Cys14, and is a potent stimulator of food consumption and gastric acid secretion. In contrast, orexin-B, a peptide containing 28 amino acids without disulfide bond, which has no stimulatory action of gastric acid. The objective of the present study was to characterize the receptor-mediated mechanism of orexin-A-induced stimulation of gastric acid secretion using orexin-A- These include feeding behavior (1, 3, 4), behavioral activity (5), sleep/awake (6, 7, 8), energy balance (9) and neuroendocrinological response (10) . In addition to these functions, we have shown that intracisternal but not intraperitoneal injection of orexin-A dosedespondently stimulated gastric acid secretion in conscious rats (11) . The acid stimulation by central orexin-A was completely blocked by atropine or surgical vagotomy, suggesting that orexin-A acts in the brain to stimulate gastric acid secretion through the vagal system. Considering the potent orexigenic action of orexin-A, orexin-A may be an important candidate as a mediator of the cephalic phase secretion as proposed by Pavlov (12) . The vagal dependent stimulation of gastric acid secretion of orexin-A furthermore support the hypothesis that orexin-A may play a vital role in cephalic phase gastric secretion because it has been recognized the importance of vagus in conveying the neural impulses that mediate cephalic phase gastric secretion.
We have examined the effect of intracisternal injection of orexin-A and -B on gastric acid secretion and demonstrated clearly that the acid stimulation was induced by orexin-A but not orexin-B (13). It has been so far shown that orexins bind to two specific receptors, named OX1R and OX2R. According to in vitro binding and functional assays, OX1R is selective for orexin-A and OX2R is non-selective for orexin-A and orexin-B
(1). Based upon the finding, the lack of acid stimulatory action of orexin-B may suggest that orexin-A-induced acid stimulation may be mediated by OX1R. On the basis of amino acid sequence, orexin-A is a 33-amino acid peptide with an N-terminal pyroglutamyl residue and C-terminal amidation.
Orexin-B contains 28 amino acid with C-terminal amidation and is 46 % (13/28) identical in sequence to orexin-A (1). In addition to the difference of number of amino acid, the major difference in peptide structure between orexin-A and -B is existence or lack of disulfide bonds, respectively. Little is however known about the structure requirements of orexin-A for biological activity. In the present study, we synthesized orexin-A-related peptides with modification of the disulfide bonds and examined the effect of the peptides on gastric acid secretion and the potency of activation of orexin receptors in order to clarify the receptor-mediated mechanism of the orexin-A-induced acid stimulation. 
Materials and Methods

Animals
Measurements of gastric acid output
Gastric acid secretion was measured using the pylorus-ligation method as described previously (11, 13) . Rats received intracisternal injection of orexin-A, orexin-B, orexin-A (15-33) or orexin-A analogues in a dose of 10 µg/10 µl. The doses used in this study were basically selected according to our previous study (11) . Control animals were injected with normal saline (10 µl ] orexin-A did not reach to the statistical significant when compared with saline.
Orexin-A and its related peptides induced a transient increase in [Ca
2+
]i in CHO/OX1R or OX2R cells in a dose-dependent manner (Fig. 3) . Table 1 
Discussion
The present study first clearly demonstrated that the stimulation of gastric acid secretion was observed by orexin-A but not orexin-A ( response and gastric secretion (1, 3, 5, 9, 10, 11). However, these evidence came from experimental data obtained by injection of synthetic orexins into the cerebrospinal fluid, indicating that we could not exclude the possibility that these orexin-A-induced changes exert through known orexin receptorsindependent pathways. It might be novel for the present study to suggest that the stimulation of gastric acid secretion may be mediated indeed by its specific receptor, OX1R.
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Trivedi et al. have reported the distribution of orexin receptor mRNA in the rat brain (14) . According to their data, OX1R and OX2R exhibited markedly differential distribution. For instance, high levels of OX1R mRNA is detected in locus coeruleus whereas OX2R is not expressed in the brain site. Contrary, neurons in the paraventricular hypothalamic nucleus express OX2R but not OX1R. In addition to the locus coeruleus, the lateroanterior hypothalamic nucleus, ventromedial hypothalamic nucleus, amygdalohippocampal area, and dorsal and median raphe highly express OX1R. Immunohistochemical studies have shown that orexinimmunoreactive fibers and terminals are richly distributed in these brain sites (15, 16, 17) . It is therefore speculated that the site of action of orexin-A to stimulate gastric acid secretion should be in the brain nuclei that express OX1R because the orexin-A-induced stimulation of gastric acid should be mediated through the action of OX1R as shown in this study.
In summary, the present study suggest that orexin-A-induced stimulation of gastric acid secretion is exerted through the action of OX1R
and that the two disulfide bonds in orexin-A have a key role in activating OX1R to stimulate the neuronal system for gastric acid production. 
------------------------------------------------------------------------------------
The concentration of orexin-A and related peptides required to induce halfmaximum response (EC50) represents the mean ± SE of three individual determinants performed in quadruplicate. 
